Brazil researchers report disappointing 50.4% efficacy for China’s CoronaVac vaccine

NEWSBUZZ
RIO DE JANEIRO: A coronavirus vaccine developed by China’s Sinovac showed “general efficacy” of 50.4% in a late-stage trial in Brazil, researchers said on Tuesday, barely enough for regulatory approval and far short of earlier indications.
The latest results are a major disappointment for…

VIEWNOW COMPLETE CONTENT

Like
Love
Haha
Wow
Sad
Angry
You have reacted on"Brazil researchers report disappointing 50.4% e..." A few seconds ago